Teledermatology in Community Settings for Prompt Evaluation of Suspected Skin Cancer: A Cost-Effectiveness Analysis and Discrete Event Simulation Study - Scorecard - MDSpire

Teledermatology in Community Settings for Prompt Evaluation of Suspected Skin Cancer: A Cost-Effectiveness Analysis and Discrete Event Simulation Study

  • By

  • Tim C H Hoogenboom

  • Pablo García Martínez

  • Piyush Mahapatra

  • Nurul Ain Nizar

  • April 6, 2026

  • 0 min

Share

Clinical Scorecard: Teledermatology in Community Settings for Prompt Evaluation of Suspected Skin Cancer: A Cost-Effectiveness Analysis and Discrete Event Simulation Study

At a Glance

CategoryDetail
ConditionSkin Cancer
Key MechanismsCommunity-based teledermatology using the Pathpoint eDerma digital platform for image capture and remote assessment.
Target PopulationPatients referred by GPs to the urgent suspected skin cancer pathway with 2 or fewer suspicious lesions.
Care SettingCommunity diagnostic centers (CDC) in Bury, part of the Northern Care Alliance NHS Foundation Trust.

Key Highlights

  • Rising incidence of skin cancer in the UK, with significant financial implications for the NHS.
  • Teledermatology addresses workforce constraints and improves patient access.
  • Community-based model enhances image capture quality and reduces patient travel.

Guideline-Based Recommendations

Diagnosis

  • Utilize community-based teledermatology for timely skin lesion assessment.

Management

  • Prioritize urgent suspected cancer pathway referrals to meet the Faster Diagnosis Standard.

Monitoring & Follow-up

  • Evaluate patient waiting times and resource utilization in teledermatology models.

Risks

  • Potential for low conversion rates of referrals indicating benign lesions.

Patient & Prescribing Data

Patients with suspected skin cancer referred by GPs.

Early diagnosis is crucial for reducing treatment costs and improving patient outcomes.

Clinical Best Practices

  • Implement high-quality image capture protocols in teledermatology.
  • Ensure integration of teledermatology services with existing healthcare pathways.

References

Original Source(s)

Related Content